Skip to content

Lipid-induced mitochondrial dysfunction in type 2 diabetes.

Skeletal Muscle Insulin Resistance: potential mechanisms and effect of weight-loss and exercise.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON20007
Enrollment
60
Registered
2009-10-22
Start date
2005-01-02
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes, first-degree relatives of type 2 diabetic patients, insulin resistance, mitochondrial function

Interventions

Sponsors

Maastricht University Medical Centre, Maastricht, The Netherlands.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Well controlled type 2 diabetic patients; 2. Normoglycemic first-degree relatives with at least one first-line family member diagnosed with type 2 diabetes; 3. Normoglycemic control subjects; 4. BMI 27 - 30 kg/m2; 5. Age 50- 70 y.

Exclusion criteria

Exclusion criteria: 1. Uncontrolled hypertension; 2. Active cardiovascular disease; 3. Liver disfunction; 4. Medication known to interfere with glucose metabolism (except for diabetic patients).

Design outcomes

Primary

MeasureTime frame
1. Ex vivo mitochondrial function; 2. In vivo mitochondrial function; 3. Insulin sensitivity; 4. Fat accumulation in muscle and heart; 5. Indirect calorimetry.

Secondary

MeasureTime frame
1. Plasma glucose; 2. Plasma insulin; 3. Plasma free fatty acids;

Contacts

Public ContactPatrick Schrauwen

Postbus 616 Department of Human Biology Maastricht University Medical Center

p.schrauwen@hb.unimaas.nl+31(0)43-388 15 02

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)